Company Profile

  1. You are here:    Home
  2. Search Databases
  3. Search Company Registry
  4. Company Profile

EnGen Bio Inc
Profile last edited on: 8/10/20      CAGE: 6R7G7      UEI:

Business Identifier: vaccines, therapeutic proteins, and antibody products
Year Founded
----
First Award
2012
Latest Award
2012
Program Status
Inactive
Popularity Index

Edit Company Profile

Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
  Explanation Edit

Location Information

61 Avondale Avenue
Redwood City, CA 94062
   (650) 440-1921
   malfenito@engenbio.com
   www.engenbio.com
Location: Single
Congr. District: 14
County: San Mateo

Public Profile

EnGen is developing an internal pipeline of vaccines, therapeutic proteins, and antibody products.

Extent of SBIR involvement

User Avatar
Phase I Awards
1
Phase II Awards
0
Conversion Rate
0.00%
Phase I Dollars
$150,000
Phase II Dollars
$0
Total Awarded
$150,000

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
1-4

Awards Distribution by Agency

Most Recent SBIR Projects
Year Phase Agency Total Amount
2012 1 NSF $150,000
Project Title: Glycoengineering of Myceliophthora

Key People / Management

  Mark Alfenito -- President and Chief Executive Officer

Company News

May 02 2011
Dyadic Netherlands Enters Into R&D Collaboration With Sanofi Pasteur and EnGen Bio